Delande Simon, Lavand'homme Patricia
Department of Anesthesiology, Cliniques Universitaires St Luc - University Catholic of Louvain, Brussels, Belgium.
Curr Opin Anaesthesiol. 2023 Apr 1;36(2):222-227. doi: 10.1097/ACO.0000000000001239. Epub 2023 Jan 12.
The acute inflammatory reaction induced by tissue trauma causes pain but also promotes recovery. Recovery is highly variable among peoples. Effective acute pain (AP) management is very important but remains suboptimal what could affect long term outcomes. The review questions the impact of either failure or effectiveness of AP treatments and the choice of analgesic drugs on different long-term outcomes after tissue trauma.
Pain control during mobilization is mandatory to reduce the risk of complications which exacerbate and prolong the inflammatory response to trauma, impairing physical recovery. Common analgesic treatments show considerable variability in effectiveness among peoples what argues for an urgent need to develop personalized AP management, that is, finding better responders to common analgesics and targeting challenging patients for more invasive procedures. Optimal multimodal analgesia to spare opioids administration remains a priority as opioids may enhance neuroinflammation, which underlies pain persistence and precipitates neurocognitive decline in frail patients. Finally, recent findings demonstrate that AP treatments which modulate nociceptive and inflammatory pain should be used with caution as drugs which inhibit inflammation like nonsteroidal antiinflammatory drugs and corticoids might interfere with natural recovery processes.
Effective and safe AP management is of far greater importance than previously realized. Evidence of suboptimal AP management in many patients and recent reports pointing out the impact of current treatments on long term outcomes argue for further research in the field.
组织创伤引发的急性炎症反应会导致疼痛,但也有助于恢复。不同个体的恢复情况差异很大。有效的急性疼痛(AP)管理非常重要,但目前仍未达到最佳状态,这可能会影响长期预后。本综述探讨了AP治疗失败或有效以及镇痛药物的选择对组织创伤后不同长期预后的影响。
活动期间的疼痛控制对于降低并发症风险至关重要,这些并发症会加剧并延长对创伤的炎症反应,从而损害身体恢复。常见的镇痛治疗在不同个体中的有效性差异很大,这表明迫切需要制定个性化的AP管理方案,即找出对常见镇痛药反应更好的患者,并针对具有挑战性的患者采取更具侵入性的治疗措施。尽量减少阿片类药物的使用,优化多模式镇痛仍然是一个优先事项,因为阿片类药物可能会增强神经炎症,而神经炎症是疼痛持续存在的基础,并会促使体弱患者出现神经认知功能下降。最后,最近的研究结果表明,应谨慎使用调节伤害性和炎症性疼痛的AP治疗方法,因为像非甾体抗炎药和皮质类固醇等抑制炎症的药物可能会干扰自然恢复过程。
有效且安全的AP管理比之前意识到的更为重要。许多患者AP管理未达最佳状态的证据以及近期报告指出当前治疗对长期预后的影响,都表明该领域需要进一步研究。